BlackBerry (BB) Q2 2027 Earnings Call Transcript

BlackBerry reported fiscal Q2 revenue of $163.3 million, up 26% year over year, while adjusted EBITDA rose 81% to $47.0 million (29% margin) and GAAP net income reached $33.9 million. Record QNX revenue of $80.3 million, up 27%, was supported by automotive royalties and a $100 million estimated-royalty Alloy Core design win with Cortica; the platform's ASP is about 3x that of traditional QNX deployments. Management raised full-year revenue guidance to $616-$636 million, adjusted EBITDA to $141-$158 million, adjusted EPS to $0.19-$0.22, and operating cash-flow guidance to roughly $115 million, though it reduced Secure Communications expectations amid geopolitical and U.S.-Canada trade-related uncertainty affecting government deal timing.

Analysis

BB is transitioning from a turnaround/security-software multiple toward an embedded-platform valuation, but the re-rating will depend on investors underwriting royalty conversion rather than design-win headline value. The key incremental positive is contractual minimum volumes: if adopted broadly, they reduce the historic gap between automotive backlog and cash realization, supporting a lower risk discount rate and higher EV/EBITDA multiple. The counterweight is that the highest-margin quarterly upside included licensing, which should not be annualized; the next two quarters must demonstrate that QNX royalty mix—not episodic IP settlements—is carrying EBITDA and cash flow.

Alloy Core creates a potentially more valuable competitive position than a stand-alone RTOS because it shifts BB from a component supplier toward an integration-layer vendor. That raises switching costs for OEMs, but also puts BB in more direct competition with automotive middleware and systems-integration vendors such as Aptiv (APTV), Continental and private Vector; OEM concentration and program-cycle risk therefore rise alongside ASP. NVDA, QCOM and NXPI benefit indirectly if safety-certified software accelerates centralized-compute adoption, though BB's platform expansion could modestly reduce OEM bargaining power versus silicon vendors over time.

Near term, the setup is constructive but likely volatile: the market will focus on a sequentially softer implied QNX exit rate and uncertainty around federal procurement, rather than long-dated design wins. Over 1-3 months, evidence of a second Alloy Core award, disclosed contracted-volume economics, or continued royalty-led margin expansion can sustain upside. The thesis is falsified by QNX growth falling below the raised annual trajectory, operating cash flow missing despite reported EBITDA, or Secure Communications renewals/retention weakening enough to turn a timing issue into an ARR contraction. Contrarian view: the physical-AI/robotaxi narrative is too early to model; BB should earn its valuation on automotive royalty conversion first, with robotics as free optionality rather than a near-term revenue driver.

Key Decisions for Investors

• Initiate a measured long BB only on post-earnings consolidation or confirmation that QNX royalty revenue remains above its guided growth trajectory in the next report; target a 6-12 month holding period. Size as a high-volatility small-cap software/auto exposure, with thesis review if QNX guidance is cut or cash conversion materially trails EBITDA.
• Express the cleaner relative-value view as long BB / short APTV in equal beta-adjusted dollars for 3-6 months: BB has incremental platform-content and royalty-conversion optionality, while APTV remains more exposed to OEM production volumes and hardware/integration margin pressure. Exit if BB fails to secure further platform wins or if APTV demonstrates materially stronger booking momentum.
• Do not chase UBER on the announced software relationship. The likely economics are immaterial to UBER's near-term P&L; use UBER only as a watch item for evidence that robotaxi fleet deployment is accelerating, which would validate BB's longer-duration embedded-software opportunity.
• Set an event alert for acquisitions in JEM/robotics. A cash-funded deal at an aggressive revenue multiple or one that dilutes QNX margins would be a sell/reduce catalyst; an acquisition with established safety-critical recurring revenue and distribution into industrial or medical markets would strengthen the 12-18 month case.